Cargando…
Analysis of Radiation Facility Volume and Survival in Men With Lymph Node–Positive Prostate Cancer Treated With Radiation and Androgen Deprivation Therapy
IMPORTANCE: Long-term control of node-positive (N1) prostate cancer, the incidence of which is increasing, is obtainable with aggressive treatment, and definitive external beam radiation therapy (EBRT) with long-term androgen deprivation therapy (ADT) is an increasingly preferred option. Caring for...
Autores principales: | Patel, Sagar A., Goyal, Subir, Liu, Yuan, Moghanaki, Drew, Patel, Pretesh R., Hanasoge, Sheela, Dhere, Vishal R., Shelton, Jay W., Godette, Karen D., Jani, Ashesh B., Hershatter, Bruce, Fischer-Valuck, Benjamin W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729429/ https://www.ncbi.nlm.nih.gov/pubmed/33301015 http://dx.doi.org/10.1001/jamanetworkopen.2020.25143 |
Ejemplares similares
-
Radiation Facility Volume and Survival for Men With Very High-Risk Prostate Cancer Treated with Radiation and Androgen Deprivation Therapy
por: Sebastian, Nikhil, et al.
Publicado: (2023) -
Influence of Timing Between Androgen Deprivation Therapy and External Beam Radiation Therapy in Patients With Localized, High-Risk Prostate Cancer
por: McCall, Neal S., et al.
Publicado: (2021) -
Overall Survival After Treatment of Localized Prostate Cancer With Proton Beam Therapy, External-Beam Photon Therapy, or Brachytherapy
por: Liu, Yuan, et al.
Publicado: (2020) -
Stereotactic body radiotherapy versus conventional/moderate fractionated radiation therapy with androgen deprivation therapy for unfavorable risk prostate cancer
por: Patel, Sagar A., et al.
Publicado: (2020) -
Stereotactic body radiation therapy use for high risk prostate cancer in the United States
por: Patel, Sagar A., et al.
Publicado: (2020)